Michael Barbella, Managing Editor06.13.24
Kardium Inc. has successfully treated several patients by delivering therapy in both the left and right atria.
After successfully completing pulmonary vein isolation (PVI) and posterior wall ablation in the left atrium, physicians subsequently re-deployed the Globe Catheter in the right atrium, and successful therapy was delivered for right atrial cavotricuspid isthmus (CTI) dependent atrial flutter (AFL). The ablation procedures were also completed using pulsed field (PF) energy, radiofrequency (RF) energy, or a hybrid combination of both, all using sedation without the need for general anesthesia.
“We are excited to continue to develop and demonstrate the capabilities and flexibility of the Globe System and its ability to deliver a treatment for AF, all with a single system,” Kardium CEO Kevin Chaplin said. “The ability to treat both the left and right atria, and the use of both RF and PF for creating lesions, gives electrophysiologists more capabilities to treat a wide range of arrythmias using the energy that is most suitable for the desired treatment.”
Atrial flutter, the second most common cardiac arrhythmia after atrial fibrillation, frequently accompanies atrial fibrillation.1 In the United States, about 200,000 new cases of atrial flutter arise annually,2 with CTI-line ablation being the preferred approach to prevent atrial flutter occurrences.
“Treating CTI-dependent atrial flutter with the Globe System showcases a differentiating approach in ablation catheter technology. The versatility to perform ablation using RF or PF, or a combination of the two, could lead to safer procedures for patients," stated Dr. Vivek Reddy of The Mount Sinai Hospital in New York, N.Y. "The procedures were performed under deep sedation, reducing overall procedure time and facilitating rapid recovery for the patient.”
The Globe System features the Globe Catheter with 122 gold electrodes, each of which can map a patient’s cardiac anatomy and electrical activity and deliver radiofrequency or pulsed field energy to the heart. The Globe Catheter sensors are used to create a proprietary CONTACT Map to identify electrodes in contact with cardiac tissue, helping to confirm therapy delivery.
Kardium Inc. is a privately held medical solutions company that has developed an advanced system for atrial fibrillation (AF) treatment: the Globe System. Founded in 2007 and headquartered in Vancouver, Canada, Kardium has consistently ranked as one of the top companies to work for in British Columbia.
References
1 Ziccardi MR. Atrial flutter. StatPearls [Internet]. December 8, 2022. Accessed April 25, 2024. https://www.ncbi.nlm.nih.gov/books/NBK540985/#.
2 Granada J, Uribe W, Chyou P-H, et al. Incidence and predictors of atrial flutter in the general population. Journal of the American College of Cardiology. 2000;36(7):2242-2246. doi:10.1016/s0735-1097(00)00982-7
After successfully completing pulmonary vein isolation (PVI) and posterior wall ablation in the left atrium, physicians subsequently re-deployed the Globe Catheter in the right atrium, and successful therapy was delivered for right atrial cavotricuspid isthmus (CTI) dependent atrial flutter (AFL). The ablation procedures were also completed using pulsed field (PF) energy, radiofrequency (RF) energy, or a hybrid combination of both, all using sedation without the need for general anesthesia.
“We are excited to continue to develop and demonstrate the capabilities and flexibility of the Globe System and its ability to deliver a treatment for AF, all with a single system,” Kardium CEO Kevin Chaplin said. “The ability to treat both the left and right atria, and the use of both RF and PF for creating lesions, gives electrophysiologists more capabilities to treat a wide range of arrythmias using the energy that is most suitable for the desired treatment.”
Atrial flutter, the second most common cardiac arrhythmia after atrial fibrillation, frequently accompanies atrial fibrillation.1 In the United States, about 200,000 new cases of atrial flutter arise annually,2 with CTI-line ablation being the preferred approach to prevent atrial flutter occurrences.
“Treating CTI-dependent atrial flutter with the Globe System showcases a differentiating approach in ablation catheter technology. The versatility to perform ablation using RF or PF, or a combination of the two, could lead to safer procedures for patients," stated Dr. Vivek Reddy of The Mount Sinai Hospital in New York, N.Y. "The procedures were performed under deep sedation, reducing overall procedure time and facilitating rapid recovery for the patient.”
The Globe System features the Globe Catheter with 122 gold electrodes, each of which can map a patient’s cardiac anatomy and electrical activity and deliver radiofrequency or pulsed field energy to the heart. The Globe Catheter sensors are used to create a proprietary CONTACT Map to identify electrodes in contact with cardiac tissue, helping to confirm therapy delivery.
Kardium Inc. is a privately held medical solutions company that has developed an advanced system for atrial fibrillation (AF) treatment: the Globe System. Founded in 2007 and headquartered in Vancouver, Canada, Kardium has consistently ranked as one of the top companies to work for in British Columbia.
References
1 Ziccardi MR. Atrial flutter. StatPearls [Internet]. December 8, 2022. Accessed April 25, 2024. https://www.ncbi.nlm.nih.gov/books/NBK540985/#.
2 Granada J, Uribe W, Chyou P-H, et al. Incidence and predictors of atrial flutter in the general population. Journal of the American College of Cardiology. 2000;36(7):2242-2246. doi:10.1016/s0735-1097(00)00982-7